Trial Profile
SWiss Atorvastatin and Interferon-Beta 1b Trial In Multiple Sclerosis - Follow up Study ("SWABIMS Follow Up-study") [EXTENSION OF 700018931]
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Interferon beta-1b
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 10 Mar 2013 New trial record